Segment Information by Division

For the Period January 1 to December 31

2015

 Download XLS

 

  

 

€ million

  

Silicones

  

Polymers

  

Bio­solutions

  

Polysilicon

  

Siltronic

  

Other

  

Conso­lidation

  

Group

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

1

Intangible assets; property, plant and equipment; investment property

 

The segment information by division is an integral part of the Notes to the Consolidated Financial Statements. For explanations of the key indicators, see Note 22.

External sales

  

1,942.8

  

1,162.5

  

197.1

  

978.9

  

923.8

  

91.1

  

–

  

5,296.2

Internal sales

  

0.5

  

23.0

  

–

  

84.7

  

7.5

  

106.4

  

-222.1

  

–

Total sales

  

1,943.3

  

1,185.5

  

197.1

  

1,063.6

  

931.3

  

197.5

  

-222.1

  

5,296.2

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

EBIT

  

194.5

  

184.4

  

21.0

  

162.6

  

4.5

  

-94.5

  

0.9

  

473.4

Depreciation and impairment losses / reversals

  

81.7

  

37.8

  

11.2

  

239.8

  

119.5

  

85.6

  

-0.2

  

575.4

EBITDA

  

276.2

  

222.2

  

32.2

  

402.4

  

124.0

  

-8.9

  

0.7

  

1,048.8

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

EBIT includes:

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Result from investments in joint ventures and associates

  

3.3

  

–

  

–

  

–

  

–

  

–

  

–

  

3.3

Asset additions1

  

82.0

  

47.4

  

6.2

  

581.8

  

75.1

  

41.5

  

–

  

834.0

Asset additions

  

82.0

  

47.4

  

6.2

  

581.8

  

75.1

  

41.5

  

–

  

834.0

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Assets (Dec. 31)

  

1,309.3

  

589.9

  

149.3

  

3,132.0

  

1,016.1

  

1,096.3

  

-28.5

  

7,264.4

Liabilities (Dec. 31)

  

749.0

  

281.1

  

67.0

  

1,392.0

  

543.5

  

1,451.5

  

-14.8

  

4,469.3

Net assets (Dec. 31)

  

560.3

  

308.8

  

82.3

  

1,740.0

  

472.6

  

-355.2

  

-13.7

  

2,795.1

Investments in joint ventures and associates included in net assets (Dec. 31)

  

21.2

  

–

  

–

  

–

  

–

  

–

  

–

  

21.2

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Research and development expenses

  

35.8

  

14.8

  

6.1

  

15.3

  

64.3

  

42.8

  

-3.8

  

175.3

Employees (Dec. 31)

  

4,353

  

1,461

  

491

  

2,373

  

3,894

  

4,400

  

–

  

16,972

Employees (average)

  

4,348

  

1,442

  

491

  

2,278

  

4,004

  

4,374

  

–

  

16,937

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

2014

 Download XLS

 

  

 

€ million

  

Silicones

  

Polymers

  

Bio­solutions

  

Polysilicon

  

Siltronic

  

Other

  

Conso­lidation

  

Group

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

1

Intangible assets; property, plant and equipment; investment property

 

The segment information by division is an integral part of the Notes to the Consolidated Financial Statements. For explanations of the key indicators, see Note 22.

External sales

  

1,733.3

  

1,040.5

  

176.2

  

949.5

  

848.0

  

78.9

  

–

  

4,826.4

Internal sales

  

0.3

  

23.9

  

–

  

99.6

  

5.4

  

87.0

  

-216.2

  

–

Total sales

  

1,733.6

  

1,064.4

  

176.2

  

1,049.1

  

853.4

  

165.9

  

-216.2

  

4,826.4

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

EBIT

  

128.9

  

118.7

  

13.6

  

305.3

  

-43.5

  

-75.4

  

-4.3

  

443.3

Depreciation and impairment losses / reversals

  

80.9

  

30.8

  

10.0

  

231.7

  

157.5

  

88.1

  

–

  

599.0

EBITDA

  

209.8

  

149.5

  

23.6

  

537.0

  

114.0

  

12.7

  

-4.3

  

1,042.3

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

EBIT includes:

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Income from investments in joint ventures and associates

  

2.9

  

–

  

–

  

–

  

–

  

–

  

–

  

2.9

Impairment losses

  

–

  

–

  

–

  

–

  

-9.5

  

–

  

–

  

-9.5

Asset additions1

  

88.5

  

56.3

  

8.4

  

334.5

  

40.7

  

43.8

  

–

  

572.2

Asset additions

  

88.5

  

56.3

  

8.4

  

334.5

  

40.7

  

43.8

  

–

  

572.2

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Assets (Dec. 31)

  

1,255.1

  

546.4

  

145.7

  

2,620.7

  

1,044.1

  

1,535.1

  

-199.9

  

6,947.2

Liabilities (Dec. 31)

  

762.1

  

297.9

  

75.2

  

1,623.9

  

758.8

  

1,668.0

  

-185.2

  

5,000.7

Net assets (Dec. 31)

  

493.0

  

248.5

  

70.5

  

996.8

  

285.3

  

-132.9

  

-14.7

  

1,946.5

Investments in joint ventures and associates included in net assets (Dec. 31)

  

20.5

  

–

  

–

  

–

  

–

  

–

  

–

  

20.5

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Research and development expenses

  

39.5

  

13.2

  

6.7

  

18.7

  

64.6

  

40.4

  

–

  

183.1

Employees (Dec. 31)

  

4,240

  

1,408

  

484

  

2,093

  

4,165

  

4,313

  

–

  

16,703

Employees (average)

  

4,201

  

1,400

  

476

  

2,083

  

4,263

  

4,321

  

–

  

16,744